NEW YORK (GenomeWeb) – Curetis announced today that it has extended an exclusive distribution agreement with Beijing Clear Biotech (BCB), expanding it from five years to eight years following the first Chinese regulatory approval. 

The strategic collaboration covers distribution of the Curetis Unyvero A50 platform and assay cartridges in China. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.